Paroxysmal Nocturnal Hemoglobinuria

Overview

Journal Int J Hematol

Specialty Hematology

Date 2006 Mar 15

PMID 16533745

Citations 4

Authors

Mitsuhiro Omine

Taroh Kinoshita

Hideki Nakakuma

Jaroslaw P Maciejewski

Charles J Parker

Gerard Socie

Affiliations

Soon will be listed here.

Citing Articles

Soluble Membrane Attack Complex: Biochemistry and Immunobiology.

Barnum S, Bubeck D, Schein T Front Immunol. 2020; 11:585108.

PMID: 33240274 PMC: 7683570. DOI: 10.3389/fimmu.2020.585108.

Short toxin-like proteins attack the defense line of innate immunity.

Tirosh Y, Ofer D, Eliyahu T, Linial M Toxins (Basel). 2013; 5(7):1314-31.

PMID: 23881252 PMC: 3737499. DOI: 10.3390/toxins5071314.

Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review.

Malato A, Saccullo G, Lo Coco L, Mancuso S, Santoro M, Martino S Blood Transfus. 2012; 10(4):428-35.

PMID: 22790262 PMC: 3496228. DOI: 10.2450/2012.0161-11.

Venous and arterial thrombosis: Two aspects of the same disease?.

Prandoni P Clin Epidemiol. 2010; 1:1-6.

PMID: 20865079 PMC: 2943163. DOI: 10.2147/clep.s4780.

References

Dunn D, Tanawattanacharoen P, Boccuni P, Nagakura S, Green S, Kirby M . Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med. 1999; 131(6):401-8. DOI: 10.7326/0003-4819-131-6-199909210-00002. View

Socie G, Mary J, de Gramont A, Rio B, Leporrier M, Rose C . Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet. 1996; 348(9027):573-7. DOI: 10.1016/s0140-6736(95)12360-1. View

Wang H, Chuhjo T, Yasue S, Omine M, Nakao S . Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood. 2002; 100(12):3897-902. DOI: 10.1182/blood-2002-03-0799. View

Hillmen P, Lewis S, Bessler M, Luzzatto L, Dacie J . Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995; 333(19):1253-8. DOI: 10.1056/NEJM199511093331904. View

Frickhofen N, Heimpel H, Kaltwasser J, Schrezenmeier H . Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood. 2002; 101(4):1236-42. DOI: 10.1182/blood-2002-04-1134. View

Nishimura J, Kanakura Y, Ware R, Shichishima T, Nakakuma H, Ninomiya H . Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore). 2004; 83(3):193-207. DOI: 10.1097/01.md.0000126763.68170.46. View

Araten D, Nafa K, Pakdeesuwan K, Luzzatto L . Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A. 1999; 96(9):5209-14. PMC: 21843. DOI: 10.1073/pnas.96.9.5209. View

Gluckman E, Scrobohaci M, Jonveaux P, Vu T, Bazarbachi A, Carosella E . Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link. Blood. 1995; 85(5):1354-63. View

Lewis S, Dacie J . The aplastic anaemia--paroxysmal nocturnal haemoglobinuria syndrome. Br J Haematol. 1967; 13(2):236-51. DOI: 10.1111/j.1365-2141.1967.tb08736.x. View

10.

Meyers G, Parker C . Management issues in paroxysmal nocturnal hemoglobinuria. Int J Hematol. 2003; 77(2):125-32. DOI: 10.1007/BF02983211. View

11.

Dacie J, Lewis S . Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology, and nature of the disease. Ser Haematol. 1972; 5(3):3-23. View

12.

Fujioka S, Asai T . Prognostic features of paroxysmal nocturnal hemoglobinuria in Japan. Nihon Ketsueki Gakkai Zasshi. 1989; 52(8):1386-94. View

13.

Nishimura J, Murakami Y, Kinoshita T . Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease. Am J Hematol. 1999; 62(3):175-82. DOI: 10.1002/(sici)1096-8652(199911)62:3<175::aid-ajh7>3.0.co;2-8. View

14.

Feng X, Chuhjo T, Sugimori C, Kotani T, Lu X, Takami A . Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. Blood. 2004; 104(8):2425-31. DOI: 10.1182/blood-2004-05-1839. View

15.

Azenishi Y, Ueda E, Machii T, Nishimura J, Hirota T, Shibano M . CD59-deficient blood cells and PIG-A gene abnormalities in Japanese patients with aplastic anaemia. Br J Haematol. 1999; 104(3):523-9. DOI: 10.1046/j.1365-2141.1999.01214.x. View

16.

Nishimura Ji , Phillips K, Ware R, Hall S, Wilson L, Gentry T . Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype. Blood. 2001; 97(10):3004-10. DOI: 10.1182/blood.v97.10.3004. View

17.

Nagakura S, Ishihara S, Dunn D, Nishimura J, Kawaguchi T, Horikawa K . Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitro. Blood. 2002; 100(3):1031-7. DOI: 10.1182/blood.v100.3.1031. View

18.

Murakami Y, Kosaka H, Maeda Y, Nishimura J, Inoue N, Ohishi K . Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria. Blood. 2002; 100(12):4116-22. DOI: 10.1182/blood-2002-06-1669. View

19.

Inoue N, Murakami Y, Kinoshita T . Molecular genetics of paroxysmal nocturnal hemoglobinuria. Int J Hematol. 2003; 77(2):107-12. DOI: 10.1007/BF02983208. View

20.

Bemba M, Guardiola P, Garderet L, Devergie A, Ribaud P, Esperou H . Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1999; 105(2):366-8. View